nodes	percent_of_prediction	percent_of_DWPC	metapath
Perflutren—Leukopenia—Bleomycin—germ cell cancer	0.00355	0.00355	CcSEcCtD
Perflutren—Angiopathy—Ifosfamide—germ cell cancer	0.00353	0.00353	CcSEcCtD
Perflutren—Immune system disorder—Ifosfamide—germ cell cancer	0.00352	0.00352	CcSEcCtD
Perflutren—Mediastinal disorder—Ifosfamide—germ cell cancer	0.00351	0.00351	CcSEcCtD
Perflutren—Chills—Ifosfamide—germ cell cancer	0.00349	0.00349	CcSEcCtD
Perflutren—Arrhythmia—Ifosfamide—germ cell cancer	0.00348	0.00348	CcSEcCtD
Perflutren—Cough—Bleomycin—germ cell cancer	0.00346	0.00346	CcSEcCtD
Perflutren—Paraesthesia—Vinblastine—germ cell cancer	0.00344	0.00344	CcSEcCtD
Perflutren—Ill-defined disorder—Dactinomycin—germ cell cancer	0.00343	0.00343	CcSEcCtD
Perflutren—Bradycardia—Cisplatin—germ cell cancer	0.00342	0.00342	CcSEcCtD
Perflutren—Erythema—Ifosfamide—germ cell cancer	0.00339	0.00339	CcSEcCtD
Perflutren—Myalgia—Bleomycin—germ cell cancer	0.00338	0.00338	CcSEcCtD
Perflutren—Chest pain—Bleomycin—germ cell cancer	0.00338	0.00338	CcSEcCtD
Perflutren—Neuropathy peripheral—Etoposide—germ cell cancer	0.00336	0.00336	CcSEcCtD
Perflutren—Coma—Methotrexate—germ cell cancer	0.00335	0.00335	CcSEcCtD
Perflutren—Discomfort—Bleomycin—germ cell cancer	0.00334	0.00334	CcSEcCtD
Perflutren—Malaise—Dactinomycin—germ cell cancer	0.00333	0.00333	CcSEcCtD
Perflutren—Leukopenia—Dactinomycin—germ cell cancer	0.00331	0.00331	CcSEcCtD
Perflutren—Connective tissue disorder—Cisplatin—germ cell cancer	0.0033	0.0033	CcSEcCtD
Perflutren—Pain—Vinblastine—germ cell cancer	0.00328	0.00328	CcSEcCtD
Perflutren—Anaphylactic shock—Bleomycin—germ cell cancer	0.00324	0.00324	CcSEcCtD
Perflutren—Oedema—Bleomycin—germ cell cancer	0.00324	0.00324	CcSEcCtD
Perflutren—Visual impairment—Cisplatin—germ cell cancer	0.00323	0.00323	CcSEcCtD
Perflutren—Vision blurred—Ifosfamide—germ cell cancer	0.00319	0.00319	CcSEcCtD
Perflutren—Feeling abnormal—Vinblastine—germ cell cancer	0.00316	0.00316	CcSEcCtD
Perflutren—Myalgia—Dactinomycin—germ cell cancer	0.00315	0.00315	CcSEcCtD
Perflutren—Ill-defined disorder—Ifosfamide—germ cell cancer	0.00314	0.00314	CcSEcCtD
Perflutren—Eye disorder—Cisplatin—germ cell cancer	0.00314	0.00314	CcSEcCtD
Perflutren—Gastrointestinal pain—Vinblastine—germ cell cancer	0.00313	0.00313	CcSEcCtD
Perflutren—Tinnitus—Cisplatin—germ cell cancer	0.00313	0.00313	CcSEcCtD
Perflutren—Lymphadenopathy—Methotrexate—germ cell cancer	0.00312	0.00312	CcSEcCtD
Perflutren—Flushing—Cisplatin—germ cell cancer	0.00311	0.00311	CcSEcCtD
Perflutren—Cardiac disorder—Cisplatin—germ cell cancer	0.00311	0.00311	CcSEcCtD
Perflutren—Agitation—Ifosfamide—germ cell cancer	0.00311	0.00311	CcSEcCtD
Perflutren—Discomfort—Dactinomycin—germ cell cancer	0.00311	0.00311	CcSEcCtD
Perflutren—Angioedema—Ifosfamide—germ cell cancer	0.0031	0.0031	CcSEcCtD
Perflutren—Hypoaesthesia—Etoposide—germ cell cancer	0.00306	0.00306	CcSEcCtD
Perflutren—Malaise—Ifosfamide—germ cell cancer	0.00306	0.00306	CcSEcCtD
Perflutren—Vertigo—Ifosfamide—germ cell cancer	0.00304	0.00304	CcSEcCtD
Perflutren—Leukopenia—Ifosfamide—germ cell cancer	0.00303	0.00303	CcSEcCtD
Perflutren—Immune system disorder—Cisplatin—germ cell cancer	0.00303	0.00303	CcSEcCtD
Perflutren—Abdominal pain—Vinblastine—germ cell cancer	0.00303	0.00303	CcSEcCtD
Perflutren—Mediastinal disorder—Cisplatin—germ cell cancer	0.00302	0.00302	CcSEcCtD
Perflutren—Hypotension—Bleomycin—germ cell cancer	0.00302	0.00302	CcSEcCtD
Perflutren—Oedema—Dactinomycin—germ cell cancer	0.00302	0.00302	CcSEcCtD
Perflutren—Arrhythmia—Cisplatin—germ cell cancer	0.003	0.003	CcSEcCtD
Perflutren—Palpitations—Ifosfamide—germ cell cancer	0.00299	0.00299	CcSEcCtD
Perflutren—Cough—Ifosfamide—germ cell cancer	0.00296	0.00296	CcSEcCtD
Perflutren—Musculoskeletal discomfort—Bleomycin—germ cell cancer	0.00295	0.00295	CcSEcCtD
Perflutren—Convulsion—Ifosfamide—germ cell cancer	0.00294	0.00294	CcSEcCtD
Perflutren—Hypertension—Ifosfamide—germ cell cancer	0.00293	0.00293	CcSEcCtD
Perflutren—Erythema—Cisplatin—germ cell cancer	0.00292	0.00292	CcSEcCtD
Perflutren—Paraesthesia—Bleomycin—germ cell cancer	0.00291	0.00291	CcSEcCtD
Perflutren—Dyspnoea—Bleomycin—germ cell cancer	0.00289	0.00289	CcSEcCtD
Perflutren—Arthralgia—Ifosfamide—germ cell cancer	0.00289	0.00289	CcSEcCtD
Perflutren—Chest pain—Ifosfamide—germ cell cancer	0.00289	0.00289	CcSEcCtD
Perflutren—Myalgia—Ifosfamide—germ cell cancer	0.00289	0.00289	CcSEcCtD
Perflutren—Eye disorder—Etoposide—germ cell cancer	0.00287	0.00287	CcSEcCtD
Perflutren—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—germ cell cancer	0.00287	0.00287	CcSEcCtD
Perflutren—Cardiac disorder—Etoposide—germ cell cancer	0.00285	0.00285	CcSEcCtD
Perflutren—Flushing—Etoposide—germ cell cancer	0.00285	0.00285	CcSEcCtD
Perflutren—Discomfort—Ifosfamide—germ cell cancer	0.00285	0.00285	CcSEcCtD
Perflutren—Hypersensitivity—Vinblastine—germ cell cancer	0.00282	0.00282	CcSEcCtD
Perflutren—Visual disturbance—Methotrexate—germ cell cancer	0.00281	0.00281	CcSEcCtD
Perflutren—Muscle spasms—Cisplatin—germ cell cancer	0.00281	0.00281	CcSEcCtD
Perflutren—Angiopathy—Etoposide—germ cell cancer	0.00279	0.00279	CcSEcCtD
Perflutren—Immune system disorder—Etoposide—germ cell cancer	0.00278	0.00278	CcSEcCtD
Perflutren—Mediastinal disorder—Etoposide—germ cell cancer	0.00277	0.00277	CcSEcCtD
Perflutren—Pain—Bleomycin—germ cell cancer	0.00277	0.00277	CcSEcCtD
Perflutren—Anaphylactic shock—Ifosfamide—germ cell cancer	0.00277	0.00277	CcSEcCtD
Perflutren—Oedema—Ifosfamide—germ cell cancer	0.00277	0.00277	CcSEcCtD
Perflutren—Chills—Etoposide—germ cell cancer	0.00276	0.00276	CcSEcCtD
Perflutren—Vision blurred—Cisplatin—germ cell cancer	0.00275	0.00275	CcSEcCtD
Perflutren—Anaphylactoid reaction—Methotrexate—germ cell cancer	0.00275	0.00275	CcSEcCtD
Perflutren—Musculoskeletal discomfort—Dactinomycin—germ cell cancer	0.00275	0.00275	CcSEcCtD
Perflutren—Asthenia—Vinblastine—germ cell cancer	0.00275	0.00275	CcSEcCtD
Perflutren—Tremor—Cisplatin—germ cell cancer	0.00274	0.00274	CcSEcCtD
Perflutren—Nervous system disorder—Ifosfamide—germ cell cancer	0.00271	0.00271	CcSEcCtD
Perflutren—Ill-defined disorder—Cisplatin—germ cell cancer	0.00271	0.00271	CcSEcCtD
Perflutren—Skin disorder—Ifosfamide—germ cell cancer	0.00269	0.00269	CcSEcCtD
Perflutren—Hyperhidrosis—Ifosfamide—germ cell cancer	0.00267	0.00267	CcSEcCtD
Perflutren—Feeling abnormal—Bleomycin—germ cell cancer	0.00267	0.00267	CcSEcCtD
Perflutren—Malaise—Cisplatin—germ cell cancer	0.00263	0.00263	CcSEcCtD
Perflutren—Diarrhoea—Vinblastine—germ cell cancer	0.00262	0.00262	CcSEcCtD
Perflutren—Dysgeusia—Etoposide—germ cell cancer	0.00262	0.00262	CcSEcCtD
Perflutren—Leukopenia—Cisplatin—germ cell cancer	0.00262	0.00262	CcSEcCtD
Perflutren—Fatigue—Dactinomycin—germ cell cancer	0.0026	0.0026	CcSEcCtD
Perflutren—Back pain—Etoposide—germ cell cancer	0.00259	0.00259	CcSEcCtD
Perflutren—Hypotension—Ifosfamide—germ cell cancer	0.00258	0.00258	CcSEcCtD
Perflutren—Pain—Dactinomycin—germ cell cancer	0.00258	0.00258	CcSEcCtD
Perflutren—Muscle spasms—Etoposide—germ cell cancer	0.00257	0.00257	CcSEcCtD
Perflutren—Urticaria—Bleomycin—germ cell cancer	0.00257	0.00257	CcSEcCtD
Perflutren—Body temperature increased—Bleomycin—germ cell cancer	0.00256	0.00256	CcSEcCtD
Perflutren—Dizziness—Vinblastine—germ cell cancer	0.00253	0.00253	CcSEcCtD
Perflutren—Convulsion—Cisplatin—germ cell cancer	0.00253	0.00253	CcSEcCtD
Perflutren—Musculoskeletal discomfort—Ifosfamide—germ cell cancer	0.00252	0.00252	CcSEcCtD
Perflutren—Myalgia—Cisplatin—germ cell cancer	0.00249	0.00249	CcSEcCtD
Perflutren—Feeling abnormal—Dactinomycin—germ cell cancer	0.00249	0.00249	CcSEcCtD
Perflutren—Paraesthesia—Ifosfamide—germ cell cancer	0.00248	0.00248	CcSEcCtD
Perflutren—Ill-defined disorder—Etoposide—germ cell cancer	0.00248	0.00248	CcSEcCtD
Perflutren—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—germ cell cancer	0.00247	0.00247	CcSEcCtD
Perflutren—Gastrointestinal pain—Dactinomycin—germ cell cancer	0.00247	0.00247	CcSEcCtD
Perflutren—Dyspnoea—Ifosfamide—germ cell cancer	0.00247	0.00247	CcSEcCtD
Perflutren—Discomfort—Cisplatin—germ cell cancer	0.00246	0.00246	CcSEcCtD
Perflutren—Vomiting—Vinblastine—germ cell cancer	0.00244	0.00244	CcSEcCtD
Perflutren—Malaise—Etoposide—germ cell cancer	0.00241	0.00241	CcSEcCtD
Perflutren—Vertigo—Etoposide—germ cell cancer	0.0024	0.0024	CcSEcCtD
Perflutren—Headache—Vinblastine—germ cell cancer	0.0024	0.0024	CcSEcCtD
Perflutren—Leukopenia—Etoposide—germ cell cancer	0.0024	0.0024	CcSEcCtD
Perflutren—Gastrointestinal disorder—Ifosfamide—germ cell cancer	0.00239	0.00239	CcSEcCtD
Perflutren—Abdominal pain—Dactinomycin—germ cell cancer	0.00239	0.00239	CcSEcCtD
Perflutren—Body temperature increased—Dactinomycin—germ cell cancer	0.00239	0.00239	CcSEcCtD
Perflutren—Fatigue—Ifosfamide—germ cell cancer	0.00238	0.00238	CcSEcCtD
Perflutren—Oedema—Cisplatin—germ cell cancer	0.00238	0.00238	CcSEcCtD
Perflutren—Anaphylactic shock—Cisplatin—germ cell cancer	0.00238	0.00238	CcSEcCtD
Perflutren—Hypersensitivity—Bleomycin—germ cell cancer	0.00238	0.00238	CcSEcCtD
Perflutren—Pain—Ifosfamide—germ cell cancer	0.00237	0.00237	CcSEcCtD
Perflutren—Loss of consciousness—Etoposide—germ cell cancer	0.00235	0.00235	CcSEcCtD
Perflutren—Nervous system disorder—Cisplatin—germ cell cancer	0.00234	0.00234	CcSEcCtD
Perflutren—Cough—Etoposide—germ cell cancer	0.00234	0.00234	CcSEcCtD
Perflutren—Tachycardia—Cisplatin—germ cell cancer	0.00233	0.00233	CcSEcCtD
Perflutren—Asthenia—Bleomycin—germ cell cancer	0.00232	0.00232	CcSEcCtD
Perflutren—Convulsion—Etoposide—germ cell cancer	0.00232	0.00232	CcSEcCtD
Perflutren—Skin disorder—Cisplatin—germ cell cancer	0.00232	0.00232	CcSEcCtD
Perflutren—Hypertension—Etoposide—germ cell cancer	0.00231	0.00231	CcSEcCtD
Perflutren—Hyperhidrosis—Cisplatin—germ cell cancer	0.00231	0.00231	CcSEcCtD
Perflutren—Pruritus—Bleomycin—germ cell cancer	0.00229	0.00229	CcSEcCtD
Perflutren—Feeling abnormal—Ifosfamide—germ cell cancer	0.00228	0.00228	CcSEcCtD
Perflutren—Chest pain—Etoposide—germ cell cancer	0.00228	0.00228	CcSEcCtD
Perflutren—Eosinophilia—Methotrexate—germ cell cancer	0.00228	0.00228	CcSEcCtD
Perflutren—Nausea—Vinblastine—germ cell cancer	0.00228	0.00228	CcSEcCtD
Perflutren—Unspecified disorder of skin and subcutaneous tissue—Etoposide—germ cell cancer	0.00226	0.00226	CcSEcCtD
Perflutren—Gastrointestinal pain—Ifosfamide—germ cell cancer	0.00226	0.00226	CcSEcCtD
Perflutren—Discomfort—Etoposide—germ cell cancer	0.00225	0.00225	CcSEcCtD
Perflutren—Hypotension—Cisplatin—germ cell cancer	0.00223	0.00223	CcSEcCtD
Perflutren—Hypersensitivity—Dactinomycin—germ cell cancer	0.00222	0.00222	CcSEcCtD
Perflutren—Urticaria—Ifosfamide—germ cell cancer	0.0022	0.0022	CcSEcCtD
Perflutren—Body temperature increased—Ifosfamide—germ cell cancer	0.00219	0.00219	CcSEcCtD
Perflutren—Abdominal pain—Ifosfamide—germ cell cancer	0.00219	0.00219	CcSEcCtD
Perflutren—Anaphylactic shock—Etoposide—germ cell cancer	0.00218	0.00218	CcSEcCtD
Perflutren—Musculoskeletal discomfort—Cisplatin—germ cell cancer	0.00217	0.00217	CcSEcCtD
Perflutren—Asthenia—Dactinomycin—germ cell cancer	0.00217	0.00217	CcSEcCtD
Perflutren—Paraesthesia—Cisplatin—germ cell cancer	0.00214	0.00214	CcSEcCtD
Perflutren—Tachycardia—Etoposide—germ cell cancer	0.00213	0.00213	CcSEcCtD
Perflutren—Dyspnoea—Cisplatin—germ cell cancer	0.00213	0.00213	CcSEcCtD
Perflutren—Skin disorder—Etoposide—germ cell cancer	0.00212	0.00212	CcSEcCtD
Perflutren—Hyperhidrosis—Etoposide—germ cell cancer	0.00211	0.00211	CcSEcCtD
Perflutren—Diarrhoea—Dactinomycin—germ cell cancer	0.00207	0.00207	CcSEcCtD
Perflutren—Gastrointestinal disorder—Cisplatin—germ cell cancer	0.00206	0.00206	CcSEcCtD
Perflutren—Vomiting—Bleomycin—germ cell cancer	0.00206	0.00206	CcSEcCtD
Perflutren—Hypotension—Etoposide—germ cell cancer	0.00204	0.00204	CcSEcCtD
Perflutren—Rash—Bleomycin—germ cell cancer	0.00204	0.00204	CcSEcCtD
Perflutren—Pain—Cisplatin—germ cell cancer	0.00204	0.00204	CcSEcCtD
Perflutren—Dermatitis—Bleomycin—germ cell cancer	0.00204	0.00204	CcSEcCtD
Perflutren—Hypersensitivity—Ifosfamide—germ cell cancer	0.00204	0.00204	CcSEcCtD
Perflutren—Conjunctivitis—Methotrexate—germ cell cancer	0.00199	0.00199	CcSEcCtD
Perflutren—Asthenia—Ifosfamide—germ cell cancer	0.00198	0.00198	CcSEcCtD
Perflutren—Feeling abnormal—Cisplatin—germ cell cancer	0.00196	0.00196	CcSEcCtD
Perflutren—Paraesthesia—Etoposide—germ cell cancer	0.00196	0.00196	CcSEcCtD
Perflutren—Pruritus—Ifosfamide—germ cell cancer	0.00196	0.00196	CcSEcCtD
Perflutren—Dyspnoea—Etoposide—germ cell cancer	0.00195	0.00195	CcSEcCtD
Perflutren—Nausea—Bleomycin—germ cell cancer	0.00192	0.00192	CcSEcCtD
Perflutren—Vomiting—Dactinomycin—germ cell cancer	0.00192	0.00192	CcSEcCtD
Perflutren—Rash—Dactinomycin—germ cell cancer	0.0019	0.0019	CcSEcCtD
Perflutren—Diarrhoea—Ifosfamide—germ cell cancer	0.00189	0.00189	CcSEcCtD
Perflutren—Gastrointestinal disorder—Etoposide—germ cell cancer	0.00189	0.00189	CcSEcCtD
Perflutren—Body temperature increased—Cisplatin—germ cell cancer	0.00188	0.00188	CcSEcCtD
Perflutren—Fatigue—Etoposide—germ cell cancer	0.00188	0.00188	CcSEcCtD
Perflutren—Pain—Etoposide—germ cell cancer	0.00187	0.00187	CcSEcCtD
Perflutren—Haemoglobin—Methotrexate—germ cell cancer	0.00185	0.00185	CcSEcCtD
Perflutren—Haemorrhage—Methotrexate—germ cell cancer	0.00184	0.00184	CcSEcCtD
Perflutren—Dizziness—Ifosfamide—germ cell cancer	0.00183	0.00183	CcSEcCtD
Perflutren—Pharyngitis—Methotrexate—germ cell cancer	0.00183	0.00183	CcSEcCtD
Perflutren—Feeling abnormal—Etoposide—germ cell cancer	0.0018	0.0018	CcSEcCtD
Perflutren—Nausea—Dactinomycin—germ cell cancer	0.00179	0.00179	CcSEcCtD
Perflutren—Gastrointestinal pain—Etoposide—germ cell cancer	0.00179	0.00179	CcSEcCtD
Perflutren—Visual impairment—Methotrexate—germ cell cancer	0.00177	0.00177	CcSEcCtD
Perflutren—Vomiting—Ifosfamide—germ cell cancer	0.00176	0.00176	CcSEcCtD
Perflutren—Hypersensitivity—Cisplatin—germ cell cancer	0.00176	0.00176	CcSEcCtD
Perflutren—Rash—Ifosfamide—germ cell cancer	0.00174	0.00174	CcSEcCtD
Perflutren—Dermatitis—Ifosfamide—germ cell cancer	0.00174	0.00174	CcSEcCtD
Perflutren—Urticaria—Etoposide—germ cell cancer	0.00174	0.00174	CcSEcCtD
Perflutren—Abdominal pain—Etoposide—germ cell cancer	0.00173	0.00173	CcSEcCtD
Perflutren—Body temperature increased—Etoposide—germ cell cancer	0.00173	0.00173	CcSEcCtD
Perflutren—Eye disorder—Methotrexate—germ cell cancer	0.00172	0.00172	CcSEcCtD
Perflutren—Tinnitus—Methotrexate—germ cell cancer	0.00172	0.00172	CcSEcCtD
Perflutren—Asthenia—Cisplatin—germ cell cancer	0.00171	0.00171	CcSEcCtD
Perflutren—Cardiac disorder—Methotrexate—germ cell cancer	0.00171	0.00171	CcSEcCtD
Perflutren—Angiopathy—Methotrexate—germ cell cancer	0.00167	0.00167	CcSEcCtD
Perflutren—Immune system disorder—Methotrexate—germ cell cancer	0.00166	0.00166	CcSEcCtD
Perflutren—Mediastinal disorder—Methotrexate—germ cell cancer	0.00166	0.00166	CcSEcCtD
Perflutren—Chills—Methotrexate—germ cell cancer	0.00165	0.00165	CcSEcCtD
Perflutren—Nausea—Ifosfamide—germ cell cancer	0.00164	0.00164	CcSEcCtD
Perflutren—Diarrhoea—Cisplatin—germ cell cancer	0.00163	0.00163	CcSEcCtD
Perflutren—Hypersensitivity—Etoposide—germ cell cancer	0.00161	0.00161	CcSEcCtD
Perflutren—Erythema—Methotrexate—germ cell cancer	0.0016	0.0016	CcSEcCtD
Perflutren—Dysgeusia—Methotrexate—germ cell cancer	0.00157	0.00157	CcSEcCtD
Perflutren—Asthenia—Etoposide—germ cell cancer	0.00157	0.00157	CcSEcCtD
Perflutren—Back pain—Methotrexate—germ cell cancer	0.00155	0.00155	CcSEcCtD
Perflutren—Pruritus—Etoposide—germ cell cancer	0.00155	0.00155	CcSEcCtD
Perflutren—Vomiting—Cisplatin—germ cell cancer	0.00152	0.00152	CcSEcCtD
Perflutren—Vision blurred—Methotrexate—germ cell cancer	0.00151	0.00151	CcSEcCtD
Perflutren—Rash—Cisplatin—germ cell cancer	0.0015	0.0015	CcSEcCtD
Perflutren—Dermatitis—Cisplatin—germ cell cancer	0.0015	0.0015	CcSEcCtD
Perflutren—Diarrhoea—Etoposide—germ cell cancer	0.00149	0.00149	CcSEcCtD
Perflutren—Ill-defined disorder—Methotrexate—germ cell cancer	0.00149	0.00149	CcSEcCtD
Perflutren—Malaise—Methotrexate—germ cell cancer	0.00145	0.00145	CcSEcCtD
Perflutren—Dizziness—Etoposide—germ cell cancer	0.00144	0.00144	CcSEcCtD
Perflutren—Vertigo—Methotrexate—germ cell cancer	0.00144	0.00144	CcSEcCtD
Perflutren—Leukopenia—Methotrexate—germ cell cancer	0.00144	0.00144	CcSEcCtD
Perflutren—Nausea—Cisplatin—germ cell cancer	0.00142	0.00142	CcSEcCtD
Perflutren—Cough—Methotrexate—germ cell cancer	0.0014	0.0014	CcSEcCtD
Perflutren—Convulsion—Methotrexate—germ cell cancer	0.00139	0.00139	CcSEcCtD
Perflutren—Vomiting—Etoposide—germ cell cancer	0.00139	0.00139	CcSEcCtD
Perflutren—Rash—Etoposide—germ cell cancer	0.00138	0.00138	CcSEcCtD
Perflutren—Dermatitis—Etoposide—germ cell cancer	0.00138	0.00138	CcSEcCtD
Perflutren—Headache—Etoposide—germ cell cancer	0.00137	0.00137	CcSEcCtD
Perflutren—Arthralgia—Methotrexate—germ cell cancer	0.00136	0.00136	CcSEcCtD
Perflutren—Chest pain—Methotrexate—germ cell cancer	0.00136	0.00136	CcSEcCtD
Perflutren—Myalgia—Methotrexate—germ cell cancer	0.00136	0.00136	CcSEcCtD
Perflutren—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—germ cell cancer	0.00136	0.00136	CcSEcCtD
Perflutren—Discomfort—Methotrexate—germ cell cancer	0.00135	0.00135	CcSEcCtD
Perflutren—Anaphylactic shock—Methotrexate—germ cell cancer	0.00131	0.00131	CcSEcCtD
Perflutren—Nausea—Etoposide—germ cell cancer	0.0013	0.0013	CcSEcCtD
Perflutren—Nervous system disorder—Methotrexate—germ cell cancer	0.00128	0.00128	CcSEcCtD
Perflutren—Skin disorder—Methotrexate—germ cell cancer	0.00127	0.00127	CcSEcCtD
Perflutren—Hyperhidrosis—Methotrexate—germ cell cancer	0.00126	0.00126	CcSEcCtD
Perflutren—Hypotension—Methotrexate—germ cell cancer	0.00122	0.00122	CcSEcCtD
Perflutren—Musculoskeletal discomfort—Methotrexate—germ cell cancer	0.00119	0.00119	CcSEcCtD
Perflutren—Paraesthesia—Methotrexate—germ cell cancer	0.00117	0.00117	CcSEcCtD
Perflutren—Dyspnoea—Methotrexate—germ cell cancer	0.00117	0.00117	CcSEcCtD
Perflutren—Dyspepsia—Methotrexate—germ cell cancer	0.00115	0.00115	CcSEcCtD
Perflutren—Gastrointestinal disorder—Methotrexate—germ cell cancer	0.00113	0.00113	CcSEcCtD
Perflutren—Fatigue—Methotrexate—germ cell cancer	0.00113	0.00113	CcSEcCtD
Perflutren—Pain—Methotrexate—germ cell cancer	0.00112	0.00112	CcSEcCtD
Perflutren—Feeling abnormal—Methotrexate—germ cell cancer	0.00108	0.00108	CcSEcCtD
Perflutren—Gastrointestinal pain—Methotrexate—germ cell cancer	0.00107	0.00107	CcSEcCtD
Perflutren—Urticaria—Methotrexate—germ cell cancer	0.00104	0.00104	CcSEcCtD
Perflutren—Body temperature increased—Methotrexate—germ cell cancer	0.00103	0.00103	CcSEcCtD
Perflutren—Abdominal pain—Methotrexate—germ cell cancer	0.00103	0.00103	CcSEcCtD
Perflutren—Hypersensitivity—Methotrexate—germ cell cancer	0.000964	0.000964	CcSEcCtD
Perflutren—Asthenia—Methotrexate—germ cell cancer	0.000939	0.000939	CcSEcCtD
Perflutren—Pruritus—Methotrexate—germ cell cancer	0.000926	0.000926	CcSEcCtD
Perflutren—Diarrhoea—Methotrexate—germ cell cancer	0.000895	0.000895	CcSEcCtD
Perflutren—Dizziness—Methotrexate—germ cell cancer	0.000865	0.000865	CcSEcCtD
Perflutren—Vomiting—Methotrexate—germ cell cancer	0.000832	0.000832	CcSEcCtD
Perflutren—Rash—Methotrexate—germ cell cancer	0.000825	0.000825	CcSEcCtD
Perflutren—Dermatitis—Methotrexate—germ cell cancer	0.000824	0.000824	CcSEcCtD
Perflutren—Headache—Methotrexate—germ cell cancer	0.00082	0.00082	CcSEcCtD
Perflutren—Nausea—Methotrexate—germ cell cancer	0.000777	0.000777	CcSEcCtD
